Accuracy and replicability of identifying eyelid tremor as an indicator of recent cannabis smoking

References

• Myers MG, Bonar EE, Bohnert KM. Driving under the influence of cannabis, alcohol, and illicit drugs among adults in the United States from 2016 to 2019. Addict Behav. 2023;140:107614. doi:10.1016/j.addbeh.2023.107614.
   PubMed Web of Science ®Google Scholar
• Kelley-Baker T, Berning A, Ramirez A, et al. 2013-2014 National roadside study of alcohol and drug use by drivers: drug results. Washington, DC: National Highway Traffic Safety Administration; 2017 (Report No. DOT HS 812 411). Available from: https://www.nhtsa.gov/sites/nhtsa.gov/files/documents/13013-nrs_drug-053117-v3-tag_0.pdf.
   Google Scholar
• Salas-Wright CP, Cano M, Hai AH, et al. Prevalence and correlates of driving under the influence of cannabis in the US. Am J Prev Med. 2021;60(6):e251–e260. doi:10.1016/j.amepre.2021.01.021.
   PubMed Web of Science ®Google Scholar
• Goodman S, Wadsworth E, Leos-Toro C, et al. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy. 2020;76:102658. doi:10.1016/j.drugpo.2019.102658.
   PubMed Web of Science ®Google Scholar
• Public Safety Canada. Annual national data report to inform trends and patterns in Drug-Impaired driving. 2022, Public Safety Canada, Ottawa, ON.
   Google Scholar
• Governors Highway Safety Association. Drug imparied driving: marijuana drug-impaired driving laws. 2023 cited 2023 June 21,]; Available from: https://www.ghsa.org/state-laws/issues/drug%20impaired%20driving.
   Google Scholar
• Dellazizzo L, Potvin S, Giguère S, et al. Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta‐review of meta‐analyses. Addiction. 2022;117(7):1857–1870. doi:10.1111/add.15764.
   PubMed Web of Science ®Google Scholar
• McCartney D, Arkell TR, Irwin C, et al. Are blood and oral fluid Δ9-tetrahydrocannabinol (THC) and metabolite concentrations related to impairment? A meta-regression analysis. Neurosci Biobehav Rev. 2021;134:104433. doi:10.1016/j.neubiorev.2021.11.004.
   PubMed Web of Science ®Google Scholar
• Hasin DS. US epidemiology of cannabis use and associated problems. Neuropsychopharmacology. 2018;43(1):195–212. doi:10.1038/npp.2017.198.
   PubMed Web of Science ®Google Scholar
• Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344(feb09 2):e536–e536. doi:10.1136/bmj.e536.
   PubMedGoogle Scholar
• Li M-C, Brady JE, DiMaggio CJ, et al. Marijuana use and motor vehicle crashes. Epidemiol Rev. 2012;34(1):65–72. doi:10.1093/epirev/mxr017.
   PubMed Web of Science ®Google Scholar
• Rogeberg O. A meta-analysis of the crash risk of cannabis-positive drivers in culpability studies—avoiding interpretational bias. Accid Anal Prev. 2019;123:69–78. doi:10.1016/j.aap.2018.11.011.
   PubMed Web of Science ®Google Scholar
• Rogeberg O, Elvik R. The effects of cannabis intoxication on motor vehicle collision revisited and revised. Addiction. 2016;111(8):1348–1359. doi:10.1111/add.13347.
   PubMed Web of Science ®Google Scholar
• Hartman RL, Richman JE, Hayes CE, et al. Drug recognition expert (DRE) examination characteristics of cannabis impairment. Accid Anal Prev. 2016;92:219–229. doi:10.1016/j.aap.2016.04.012.
   PubMed Web of Science ®Google Scholar
• Arkell TR, Spindle TR, Kevin RC, et al. The failings of per se limits to detect cannabis-induced driving impairment: results from a simulated driving study. Traffic Inj Prev. 2021;22(2):102–107. doi:10.1080/15389588.2020.1851685.
   PubMed Web of Science ®Google Scholar
• National Highway Traffic Safety Administration. DWI detection and standardized field sobriety test (SFST) resources. 2023; Available from: https://www.nhtsa.gov/dwi-detection-and-standardized-field-sobriety-test-sfst-resources.
   Google Scholar
• Bosker WM, Theunissen EL, Conen S, et al. A placebo-controlled study to assess standardized field sobriety tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. Psychopharmacology (Berl). 2012;223(4):439–446. doi:10.1007/s00213-012-2732-y.
   PubMed Web of Science ®Google Scholar
• Ginsburg BC. Strengths and limitations of two cannabis-impaired driving detection methods: a review of the literature. Am J Drug Alcohol Abuse. 2019;45(6):610–622. doi:10.1080/00952990.2019.1655568.
   PubMed Web of Science ®Google Scholar
• Downey LA, King R, Papafotiou K, et al. Detecting impairment associated with cannabis with and without alcohol on the standardized field sobriety tests. Psychopharmacology (Berl). 2012;224(4):581–589. doi:10.1007/s00213-012-2787-9.
   PubMed Web of Science ®Google Scholar
• National Highway Traffic Safety Administration. Drug evaluation and classification program, advanced roadside impaired driving enforcement resources. 2018; Available from: https://www.nhtsa.gov/enforcement-justice-services/drug-evaluation-and-classification-program-advanced-roadside-impaired.
   Google Scholar
• Nguyen AX, Wu AY. Association between cannabis and the eyelids: a comprehensive review. Clin Exp Ophthalmol. 2020;48(2):230–239. doi:10.1111/ceo.13687.
   PubMed Web of Science ®Google Scholar
• Steinhart B, et al. A video segmentation pipeline for assessing changes in pupil response to light after cannabis consumption. bioRxiv. 2023 Mar 21:2023.03.17.533144. doi:10.1101/2023.03.17.533144.
   PubMedGoogle Scholar
• National Highway Traffic Safety Administration. Advanced roadside impaired driving enforcement participant guide. 2023. Available from: https://www.nhtsa.gov/sites/nhtsa.gov/files/2023-04/15941-2023_ARIDE_Participant_Guide-tag.pdf.
   Google Scholar
• Marcotte TD, Umlauf A, Grelotti DJ, et al. Evaluation of field sobriety tests for identifying drivers under the influence of cannabis: a randomized clinical trial. JAMA Psychiatry. 2023;80(9):914–923. doi:10.1001/jamapsychiatry.2023.2345.
   PubMed Web of Science ®Google Scholar
• Brooks-Russell A, Brown T, Friedman K, et al. Simulated driving performance among daily and occasional cannabis users. Accid Anal Prev. 2021;160:106326. doi:10.1016/j.aap.2021.106326.
   PubMed Web of Science ®Google Scholar
• Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–163. doi:10.1016/j.jcm.2016.02.012.
   PubMed Web of Science ®Google Scholar
• McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–282. doi:10.11613/BM.2012.031.
   PubMed Web of Science ®Google Scholar
• Schwarz LH, Stern JA. Eyelid tremulousness. A neurophysiological index of depression. Arch Gen Psychiatry. 1968;19(4):497–500. doi:10.1001/archpsyc.1968.01740100113016.
   PubMed Web of Science ®Google Scholar
• Defazio G, Jinnah HA, Berardelli A, et al. Diagnostic criteria for blepharospasm: a multicenter international study. Parkinsonism Relat Disord. 2021;91:109–114. doi:10.1016/j.parkreldis.2021.09.004.
   PubMed Web of Science ®Google Scholar
• Porath AJ, Beirness DJ. Predicting categories of drugs used by suspected drug-impaired drivers using the drug evaluation and classification program tests. Traffic Inj Prev. 2019;20(3):255–263. doi:10.1080/15389588.2018.1562178.
   PubMed Web of Science ®Google Scholar
• Helmchen C, Rambold H. The eyelid and its contribution to eye movements. Neuro-Ophthalmology. 2007;40:110–131.
   Google Scholar
• Jacome DE. Synkinetic blepharoclonus. J Neuroophthalmol. 2000;20(4):276–284. doi:10.1097/00041327-200020040-00016.
   PubMed Web of Science ®Google Scholar
• Hunault CC, Mensinga TT, de Vries I, et al. Delta-9-tetrahydrocannabinol (THC) serum concentrations and pharmacological effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg THC. Psychopharmacology (Berl). 2008;201(2):171–181. doi:10.1007/s00213-008-1260-2.
   PubMed Web of Science ®Google Scholar
• McCartney D, Arkell TR, Irwin C, et al. Determining the magnitude and duration of acute Δ(9)-tetrahydrocannabinol (Δ(9)-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review. Neurosci Biobehav Rev. 2021;126:175–193. doi:10.1016/j.neubiorev.2021.01.003.
   PubMed Web of Science ®Google Scholar